What We're Reading
Industry reads hand-picked by our editors
Aug 01, 2024
Jul 31, 2024
Jul 30, 2024
-
CNN
Ozempic predecessor suggests potential for GLP-1 drugs in Alzheimer’s in early trial
-
MIT Technology Review
Controversial CRISPR scientist promises “no more gene-edited babies” until society comes around
-
C&EN
The future of science publishing
-
NPR
Ozempic’s biggest side effect: Turning Denmark into a ‘pharmastate’?
Jul 29, 2024
Jul 26, 2024
Jul 25, 2024
Jul 24, 2024
-
The New York Times
A Disease That Makes Children Age Rapidly Gets Closer to a Cure
-
BioSpace
FDA Flags Potential ‘Overtreatment’ for NSCLC With AstraZeneca’s Imfinzi Ahead of Adcomm
-
New England Journal of Medicine
The Real Purpose of PrEP — Effectiveness, Not Efficacy